Open-label feasibility study of pazopanib, carboplatin, and paclitaxel in women with newly diagnosed, untreated, gynaecologic tumours: a phase I/II trial of the AGO study group

INTRODUCTION: Although most patients with advanced gynaecologic malignancies respond to first-line treatment with platinum-taxane doublets, a significant proportion of patients relapse. Combining targeted agents that have non-overlapping mechanisms of action with chemotherapy may potentially increas...

Descripción completa

Detalles Bibliográficos
Autores principales: du Bois, A, Vergote, I, Wimberger, P, Ray-Coquard, I, Harter, P, Curtis, L B, Mitrica, I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Clinical Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3322958/
https://www.ncbi.nlm.nih.gov/pubmed/22240783
http://dx.doi.org/10.1038/bjc.2011.608

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3322958/
https://www.ncbi.nlm.nih.gov/pubmed/22240783
http://dx.doi.org/10.1038/bjc.2011.608

Ejemplares similares